BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

728 related articles for article (PubMed ID: 27466789)

  • 1. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches.
    Fuller CD; Mohamed AS; Garden AS; Gunn GB; Mulcahy CF; Zafereo M; Phan J; Lai SY; Lewin JS; Hutcheson KA; Frank SJ; Beadle BM; Morrison WH; El-Naggar AK; Kocak-Uzel E; Ginsberg LE; Kies MS; Weber RS; Rosenthal DI
    Head Neck; 2016 Dec; 38(12):1739-1751. PubMed ID: 27466789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of survival after total laryngectomy for recurrent/persistent laryngeal squamous cell carcinoma.
    Birkeland AC; Beesley L; Bellile E; Rosko AJ; Hoesli R; Chinn SB; Shuman AG; Prince ME; Wolf GT; Bradford CR; Brenner JC; Spector ME
    Head Neck; 2017 Dec; 39(12):2512-2518. PubMed ID: 28963806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary surgery for advanced-stage laryngeal cancer: A stage and subsite-specific survival analysis.
    Harris BN; Bhuskute AA; Rao S; Farwell DG; Bewley AF
    Head Neck; 2016 Sep; 38(9):1380-6. PubMed ID: 27014858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transoral laser microsurgery for locally advanced (T3-T4a) supraglottic squamous cell carcinoma: Sixteen years of experience.
    Vilaseca I; Blanch JL; Berenguer J; Grau JJ; Verger E; Muxí Á; Bernal-Sprekelsen M
    Head Neck; 2016 Jul; 38(7):1050-7. PubMed ID: 26872432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total Laryngectomy Versus Larynx Preservation for T4a Larynx Cancer: Patterns of Care and Survival Outcomes.
    Grover S; Swisher-McClure S; Mitra N; Li J; Cohen RB; Ahn PH; Lukens JN; Chalian AA; Weinstein GS; O'Malley BW; Lin A
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):594-601. PubMed ID: 26068492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of T3N1 glottic carcinoma: therapeutic outcomes.
    Spector JG; Sessions DG; Lenox J; Simpson J
    Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transoral laser microsurgery as primary treatment for selected T3 glottic and supraglottic cancers.
    Peretti G; Piazza C; Penco S; Santori G; Del Bon F; Garofolo S; Paderno A; Guastini L; Nicolai P
    Head Neck; 2016 Jul; 38(7):1107-12. PubMed ID: 26970262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3-decade survey.
    Rosenthal DI; Mohamed AS; Weber RS; Garden AS; Sevak PR; Kies MS; Morrison WH; Lewin JS; El-Naggar AK; Ginsberg LE; Kocak-Uzel E; Ang KK; Fuller CD
    Cancer; 2015 May; 121(10):1608-19. PubMed ID: 25586197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer.
    Oksüz DC; Uzel O; Yildirim A; Yetmen O; Sahinler I; Turkan S
    J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):681-8. PubMed ID: 19128676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary total laryngectomy versus organ preservation for T3/T4a laryngeal cancer: a population-based analysis of survival.
    Dziegielewski PT; O'Connell DA; Klein M; Fung C; Singh P; Alex Mlynarek M; Fung D; Harris JR; Seikaly H
    J Otolaryngol Head Neck Surg; 2012 Apr; 41 Suppl 1():S56-64. PubMed ID: 22569051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supraglottic laryngeal cancer: analysis of treatment results.
    Sessions DG; Lenox J; Spector GJ
    Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncological outcomes of surgical treatment for T3 supraglottic laryngeal squamous cell carcinoma patients.
    Zhou J; Zhou L; Tao L; Zhang M; Wu H; Chen X; Li X; Li C; Gong H
    Acta Otolaryngol; 2018 Nov; 138(11):1028-1034. PubMed ID: 30735065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncologic outcomes of surgical treatment for T3 glottic laryngeal squamous cell carcinoma.
    Zhou J; Zhou L; Tao L; Zhang M; Wu H; Chen X; Li X; Li C; Gong H
    Head Neck; 2018 Aug; 40(8):1734-1742. PubMed ID: 29601122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.
    Patel SA; Qureshi MM; Dyer MA; Jalisi S; Grillone G; Truong MT
    Cancer; 2019 Oct; 125(19):3367-3377. PubMed ID: 31206637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience.
    Nguyen-Tan PF; Le QT; Quivey JM; Singer M; Terris DJ; Goffinet DR; Fu KK
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1172-80. PubMed ID: 11483326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of postoperative radiotherapy on survival for surgically managed pT3N0 and pT4aN0 laryngeal cancer: Analysis of the National Cancer Data Base.
    Graboyes EM; Zhan KY; Garrett-Mayer E; Lentsch EJ; Sharma AK; Day TA
    Cancer; 2017 Jun; 123(12):2248-2257. PubMed ID: 28182267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent cetuximab and postoperative radiation in resected high-risk squamous cell carcinomas of the head and neck: A single-institution experience.
    Araki D; Redman MW; Martins R; Eaton K; Baik C; Chow L; Goulart B; Lee S; Santana-Davila R; Liao J; Parvathaneni U; Laramore G; Futran N; Mendez E; Bhrany A; Rodriguez CP
    Head Neck; 2016 Sep; 38(9):1318-23. PubMed ID: 27061333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neck Management with Total Laryngectomy and Adjuvant Radiotherapy in Locally Advanced Larynx Cancer.
    Kennedy WR; Amdur RJ; Boyce BJ; Dziegielewski P; Morris CG; Mendenhall WM
    Oncol Res Treat; 2017; 40(9):503-506. PubMed ID: 28848123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery-based versus radiation-based treatment strategy for a high metabolic volume laryngeal cancer.
    Yabuki K; Sano D; Shiono O; Arai Y; Chiba Y; Tanabe T; Nishimura G; Takahashi M; Taguchi T; Kaneta T; Hata M; Oridate N
    Laryngoscope; 2017 Apr; 127(4):862-867. PubMed ID: 27576793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.